ABCG2 and neoplasm: Many studies indicate that EVs can transfer therapy resistance from resistant tumor cells to sensitive cells by increasing anti-apoptotic signaling and DNA repair or delivering ABC transporters, thus contributing to increased tumor malignancy [135].